Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Baudax Bio Inc
(NQ:
BXRX
)
N/A
UNCHANGED
Last Price
Updated: 3:50 PM EST, Nov 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Baudax Bio Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Crude Oil Down Over 2%; General Motors Raises Profit Outlook
April 25, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 100 points on Tuesday. The Dow traded down 0.19% to 33,811.66 while the NASDAQ fell 0.87% to 11,932.83. The...
Via
Benzinga
Baudax Bio's Nerve Blockade Aces Mid-Stage Study In Surgery Patients
April 25, 2023
Baudax Bio Inc (NASDAQ: BXRX) announced top-line results from its Phase 2 clinical trial of BX1000 for neuromuscular blockade (NMB) in elective surgery patients.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 25, 2023
Via
Benzinga
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
April 25, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial
April 24, 2023
Virtual Webinar to be held April 25, 2023 at 10:00 AM Eastern Time
From
Baudax Bio, Inc.
Via
GlobeNewswire
Why Baudax Bio Shares Are Trading Higher Today
March 27, 2023
Via
Benzinga
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 19, 2023
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 18, 2023
Via
Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
March 27, 2023
Via
Benzinga
Looking Into Baudax Bio's Return On Capital Employed
February 28, 2023
Via
Benzinga
Why Baudax Bio Shares Trading Higher Today
January 24, 2023
Via
Benzinga
Why Is Baudax Bio (BXRX) Stock Up 50% Today?
January 24, 2023
BXRX stock is soaring today as Baudax Bio's novel medical product could result in time and cost savings for patients and hospitals.
Via
InvestorPlace
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
March 27, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
March 16, 2023
Via
Benzinga
Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
February 23, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
February 17, 2023
Via
Benzinga
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 25, 2023
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 25, 2023
Via
Benzinga
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
January 25, 2023
Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.
Via
MarketBeat
Dow Rises 80 Points; Altamira Therapeutics Shares Plunge
January 24, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday. The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500...
Via
Benzinga
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 24, 2023
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 24, 2023
Via
Benzinga
Stocks Static As Earnings Season Heats Up
January 24, 2023
After a strong start to the week, stocks are struggling for direction today as investors unpack the latest batch of earnings reports.
Via
Talk Markets
Dow Edges Higher; Crude Oil Down 1%
January 24, 2023
U.S. stocks traded mostly flat midway through trading, with the Dow Jones trading slightly higher on Tuesday. The Dow traded up 0.03% to 33,638.42 while the NASDAQ fell 0.07% to 11,356.65. The S&P 500...
Via
Benzinga
Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast
January 24, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.31% to 33,524.12 while the NASDAQ fell...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 24, 2023
Via
Benzinga
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
January 24, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 30, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.